{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:59:11Z","timestamp":1781272751660,"version":"3.54.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012692","name":"K C Wong Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","award":["5609\/31\/18"],"award-info":[{"award-number":["5609\/31\/18"]}],"id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"TEKES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.expneurol.2025.115593","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:03:45Z","timestamp":1765422225000},"page":"115593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model"],"prefix":"10.1016","volume":"397","author":[{"given":"Tommi","family":"Kilpel\u00e4inen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyri","family":"Toivio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Etel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Fastr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna K.","family":"Uhari-V\u00e4\u00e4n\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Julku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo T.","family":"My\u00f6h\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115593_bb0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0010","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1074\/jbc.M409718200","article-title":"Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3","volume":"280","author":"Alvarado-Kristensson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0015","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s12035-018-1272-9","article-title":"AT2R activation prevents microglia pro-inflammatory activation in a NOX-dependent manner: inhibition of PKC activation and p47phox phosphorylation by PP2A","volume":"56","author":"Bhat","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0020","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.peptides.2008.05.005","article-title":"Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein","volume":"29","author":"Brandt","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2025.115593_bb0025","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.18632\/oncotarget.28041","article-title":"The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion","volume":"12","author":"Casili","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.expneurol.2025.115593_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106693","article-title":"Correlations of gray matter volume with peripheral cytokines in Parkinson\u2019s disease","volume":"201","author":"Chen","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115593_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn1298","article-title":"Regulation of \u03b1-synuclein homeostasis and inflammasome activation by microglial autophagy","volume":"8","author":"Choi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2025.115593_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12931-023-02519-x","article-title":"Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro","volume":"24","author":"Cucinotta","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.expneurol.2025.115593_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114899","article-title":"Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy","volume":"197","author":"Cui","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0050","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2025.115593_bb0055","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115593_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106077","article-title":"Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson\u2019s disease","volume":"122","author":"Espay","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115593_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2021.04.001","article-title":"Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A","volume":"169","author":"Etel\u00e4inen","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2025.115593_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109213","article-title":"Removal of proteinase K resistant \u03b1Syn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model","volume":"218","author":"Etel\u00e4inen","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115593_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq2915","article-title":"A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy","volume":"15","author":"Etel\u00e4inen","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2025.115593_bb0080","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awac326","article-title":"PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability","volume":"146","author":"Fevga","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115593_bb0085","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1074\/jbc.M115.704908","article-title":"Regulation of Beclin 1 protein phosphorylation and autophagy by protein phosphatase 2A (PP2A) and death-associated protein kinase 3 (DAPK3)","volume":"291","author":"Fujiwara","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0090","doi-asserted-by":"crossref","unstructured":"Gaggar, A., Jackson, P.L., Noerager, B.D., O'Reilly, P.J., McQuaid, D.B., Rowe, S.M., Clancy, J.P., Blalock, J.E., 2008. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J. Immunol. (Baltimore, Md.: 1950) 180, 5662-5669.","DOI":"10.4049\/jimmunol.180.8.5662"},{"key":"10.1016\/j.expneurol.2025.115593_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0100","first-page":"11","article-title":"AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease","volume":"5","author":"Ip","year":"2017"},{"key":"10.1016\/j.expneurol.2025.115593_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuint.2011.12.010","article-title":"The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum","volume":"60","author":"Jalkanen","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2025.115593_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bcpt.12184","article-title":"KYP-2047 penetrates mouse brain and effectively inhibits mouse prolyl oligopeptidase","volume":"114","author":"Jalkanen","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bcpt.12184","article-title":"KYP-2047 penetrates mouse brain and effectively inhibits mouse prolyl oligopeptidase","volume":"114","author":"Jalkanen","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0120","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/jm049503w","article-title":"A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors","volume":"47","author":"Jarho","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.21037\/atm.2020.01.14","article-title":"Prolyl endopeptidase gene disruption attenuates high fat diet-induced nonalcoholic fatty liver disease in mice by improving hepatic steatosis and inflammation","volume":"8","author":"Jiang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.expneurol.2025.115593_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","article-title":"Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice","volume":"101","author":"Karikari","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2025.115593_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110253","article-title":"The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy","volume":"128","author":"Kilpel\u00e4inen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.expneurol.2025.115593_bb0145","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1021\/acs.jmedchem.3c00235","article-title":"Nonpeptidic oxazole-based prolyl oligopeptidase ligands with disease-modifying effects on \u03b1-Synuclein mouse models of Parkinson\u2019s disease","volume":"66","author":"Kilpel\u00e4inen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0150","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/mp.2016.103","article-title":"Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects","volume":"22","author":"Kim","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115593_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/glia.20645","article-title":"Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity","volume":"56","author":"Klegeris","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2025.115593_bb0160","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1006\/cyto.2000.0688","article-title":"p38 map kinase regulates TNF-\u03b1 production in human astrocytes and microglia by multiple mechanisms","volume":"12","author":"Lee","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.expneurol.2025.115593_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jcp.10211","article-title":"Role of PP2A in the regulation of p38 MAPK activation in bovine aortic endothelial cells exposed to cyclic strain","volume":"194","author":"Lee","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0170","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/15548627.2018.1556946","article-title":"TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia","volume":"15","author":"Lee","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115593_bb0175","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115593_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","article-title":"Extensive uptake of \u03b1-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage","volume":"82","author":"Lindstr\u00f6m","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in non-transgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.expneurol.2025.115593_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2025.115593_bb0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-022-01676-x","article-title":"Role of \u03b1-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson\u2019s disease","volume":"72","author":"Lv","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.expneurol.2025.115593_bb0200","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neurobiolaging.2012.06.026","article-title":"PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins","volume":"34","author":"Magnaudeix","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2025.115593_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JPD-240272","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2024 update","volume":"14","author":"McFarthing","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115593_bb0210","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2025.115593_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-023-01402-y","article-title":"The involvement of \u03b1-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson\u2019s disease","volume":"22","author":"Miao","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.expneurol.2025.115593_bb0220","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neuroscience.2008.02.047","article-title":"Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its NK-1 receptor in the rat brain: an immunohistochemical study","volume":"153","author":"My\u00f6h\u00e4nen","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2025.115593_bb0225","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/cne.21642","article-title":"Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters","volume":"507","author":"Myohanen","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0230","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","article-title":"A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson\u2019s disease","volume":"166","author":"Myohanen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bcpt.13094","article-title":"Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target","volume":"124","author":"Natunen","year":"2019","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","article-title":"Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen","volume":"217","author":"O\u2019Reilly","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0245","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/brain\/awad247","article-title":"PTPA variants and the risk for Parkinson\u2019s disease in diverse ancestry populations","volume":"146","author":"Ostro\u017eovi\u010dov\u00e1","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115593_bb0250","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00702-025-02889-0","article-title":"Protein misfolding: understanding biology to classify and treat synucleinopathies","volume":"132","author":"Outeiro","year":"2025","journal-title":"J. Neural Transm. (Vienna)."},{"key":"10.1016\/j.expneurol.2025.115593_bb0255","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3233\/JPD-230284","article-title":"Astrocytes and alpha-synuclein: friend or foe?","volume":"13","author":"Ozoran","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115593_bb0260","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/acn3.337","article-title":"Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies","volume":"3","author":"Park","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0265","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1021\/acs.jmedchem.3c01993","article-title":"5-aminothiazoles reveal a new ligand-binding site on prolyl oligopeptidase which is important for modulation of its protein\u2013protein interaction-derived functions","volume":"67","author":"P\u00e4tsi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/187152711794653742","article-title":"Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research","volume":"10","author":"Penttinen","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2025.115593_bib426","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.expneurol.2025.115593_bb0275","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/ejn.14129","article-title":"Implementation of deep neural networks to count dopamine neurons in substantia nigra","volume":"48","author":"Penttinen","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0280","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jnc.15993","article-title":"The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias","volume":"167","author":"Rentsch","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68C","author":"Savolainen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115593_bb0290","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.M114.592931","article-title":"Prolyl oligopeptidase enhances \u03b1-synuclein dimerization via direct protein-protein interaction","volume":"290","author":"Savolainen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115593_bb0295","article-title":"Impact of hippocampal \u03b1-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies","volume":"21","author":"Sekiya","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2025.115593_bb0300","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115593_bb0305","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","article-title":"The concept of alpha-synuclein as a prion-like protein: ten years after","volume":"373","author":"Steiner","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2025.115593_bb0310","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0315","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115593_bb0320","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-5793(02)03277-5","article-title":"P38 mitogen-activated protein kinase dephosphorylation is regulated by protein phosphatase 2A in human platelets activated by collagen","volume":"528","author":"Sundaresan","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2025.115593_bb0325","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1523\/JNEUROSCI.2309-16.2016","article-title":"Inhibition of prolyl oligopeptidase restores spontaneous motor behavior in the \u03b1-synuclein virus vector\u2013based Parkinson\u2019s disease mouse model by decreasing \u03b1-synuclein oligomeric species in mouse brain","volume":"36","author":"Svarcbahs","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0330","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41598-018-19823-y","article-title":"Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo","volume":"8","author":"Svarcbahs","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115593_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104558","article-title":"Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A","volume":"151","author":"Svarcbahs","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2025.115593_bb0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/15548627.2023.2277634","article-title":"ATG5 (autophagy related 5) in microglia controls hippocampal neurogenesis in Alzheimer disease","volume":"20","author":"Tang","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115593_bb0345","first-page":"657","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev."},{"key":"10.1016\/j.expneurol.2025.115593_bb0350","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13522","article-title":"\u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease","volume":"20","author":"Tu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2025.115593_bb0355","article-title":"A prolyl oligopeptidase ligand blocks memory deficit in a repeated mild traumatic brain injury model","volume":"115454","author":"Uhari-V\u00e4\u00e4n\u00e4nen","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2025.02.003","article-title":"The prolyl oligopeptidase and \u03b1-synuclein connection revisited","volume":"233","author":"Van Elzen","year":"2025","journal-title":"Biochimie"},{"key":"10.1016\/j.expneurol.2025.115593_bb0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2025.115593_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263021","article-title":"Microglia-secreted TNF-\u03b1 affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors","volume":"18","author":"Wenker","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115593_bb0375","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.02-0314fje","article-title":"Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease","volume":"17","author":"Wilms","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2025.115593_bb0380","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115593_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2025.115593_bb0390","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1750-1326-6-84","article-title":"Microglial p38\u03b1 MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNF\u03b1","volume":"6","author":"Xing","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115593_bb0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023418118","article-title":"Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading","volume":"118","author":"Xu","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0400","doi-asserted-by":"crossref","first-page":"E12053","DOI":"10.1073\/pnas.1813365115","article-title":"Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson\u2019s disease and DLB","volume":"115","author":"Yan","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166636","article-title":"Orchestrated action of PP2A antagonizes Atg13 phosphorylation and promotes autophagy after the inactivation of TORC1","volume":"11","author":"Yeasmin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115593_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119131","article-title":"Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis","volume":"270","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2025.115593_bb0415","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.expneurol.2025.115593_bb0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-024-00846-4","article-title":"Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson\u2019s disease model triggered by \u03b1-synuclein overexpression","volume":"11","author":"Zhang","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115593_bb0425","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cellsig.2014.01.002","article-title":"PP2A\u2013AMPK\u03b1\u2013HSF1 axis regulates the metal-inducible expression of HSPs and ROS clearance","volume":"26","author":"Zhu","year":"2014","journal-title":"Cell. Signal."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:26:24Z","timestamp":1781270784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625004583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":86,"alternative-id":["S0014488625004583"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115593","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115593"}}